< Back to previous page

Publication

SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response.

Journal Contribution - Journal Article

Journal: Oncoimmunology

Volume: 11

Pages: 2139074

Publication year:2022

DOI: https://doi.org/10.1080/2162402x.2022.2139074

Accessibility:Open

See also: SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response